---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-134886"
form_type: "8-K"
ticker: "APLS"
cik: "0001492422"
company_name: "Apellis Pharmaceuticals, Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-19T23:49:31.404331+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Apellis shareholders elect three Class II directors and ratify Deloitte as auditor at 2025 annual meeting

## Summary
- Elected A. Sinclair Dunlop (54.1M for, 26.0M withheld), Alec Machiels (62.3M for, 17.8M withheld), Keli Walbert (76.95M for, 3.18M withheld) as Class II directors for three-year terms.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 103.9M for, 54.6K against, 116.2K abstain.
- Approved non-binding advisory vote on named executive officer compensation: 75.9M for, 4.17M against, 59.9K abstain.
- Recommended future say-on-pay votes every year (79.86M for 1-year); company will hold annual advisory votes.

## SEC filing metadata
- accession: 0001193125-25-134886
- form_type: 8-K
- ticker: APLS
- cik: 0001492422
- company_name: Apellis Pharmaceuticals, Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1492422/000119312525134886/0001193125-25-134886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1492422/000119312525134886/d85723d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-134886
- JSON: https://secwatch.observer/filing/0001193125-25-134886.json
- Plain text: https://secwatch.observer/filing/0001193125-25-134886.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.